ישראל -
עברית -
Ministry of Health
יינטריב 40 מג
eli lilly israel ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 40 mg - duloxetine
ישראל -
עברית -
Ministry of Health
אייבו % 2 לילדים
abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 100 mg / 5 ml - ibuprofen
ישראל -
עברית -
Ministry of Health
אייבו % 2 לילדים
abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 100 mg / 5 ml - ibuprofen
ישראל -
עברית -
Ministry of Health
"medical gels,medical device disinfectants&cleaning,hand antiseptic products,surface disinfectants,hemodialysis device cleaning
"ב.מדיקל לוגיסטיקס בע""מ " - רופא - "medical gels,medical device disinfectants&cleaning,hand antiseptic products,surface disinfectants,hemodialysis device cleaning solution,hygienic liquid soap,lead apron & accessories,hot & cold thermo gels,eeg paste,ecg spray&ecg cream,mouth care kit,stethoscope sterilization tape"
ישראל -
עברית -
Ministry of Health
מזוונט 1200 מג
takeda israel ltd - mesalazine - טבליות בשחרור ממושך - mesalazine 1200 mg - mesalazine
ישראל -
עברית -
Ministry of Health
ספייק-וקס
medison pharma ltd - cx-024414 mrna - cx-024414 mrna 1.26 mg/vial - covid-19 vaccines
ישראל -
עברית -
Ministry of Health
קסינתה 2000 יחבל
pfizer pharmaceuticals israel ltd - moroctocog alfa - אבקה וממס להכנת תמיסה להזרקה - moroctocog alfa 2000 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)
ישראל -
עברית -
Ministry of Health
בנפיקס 250 יח' בינל
pfizer pharmaceuticals israel ltd - coagulation factor ix recombinant-rfix - אבקה מיובשת בהקפאה להזרקה - coagulation factor ix recombinant-rfix 250 iu/vial - coagulation factor ix - coagulation factor ix - benefix is indicated for the control and prevention of hemorrhagic episodes in patients with hemophilia b (congenital factor ix deficiency or christmas disease), including control and prevention of bleeding in surgical settings, in previously treated patients (ptp) and previously untreated patients (pup). benefix is not indicated for the treatment of other factor deficiencies (e.g. factors ii,vii, and x)' nor for the treatment of hemophilia a patients with inhibitors to factor viii, nor for the reversal of coumarin-induced anticoagulation, nor for the treatment of bleeding due to low levels of liver-dependent coagulation factors.